Atlas Trials

Optimal ECMO Flow in the Critical Phase of Cardiogenic Shock to Optimize Peripheral Organ Perfusion and Myocardial Stress

Clinical trial NCT06936839 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06936839
Sponsor
University Hospital, Montpellier
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Cardiogenic Shock
Start date
2025-04-15
Primary completion
2026-04-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.